Related Experiment Video
Updated: Aug 29, 2025

07:44
Studying the Effects of Tumor-Secreted Paracrine Ligands on Macrophage Activation using Co-Culture with Permeable Membrane Supports
Published on: November 28, 2019
7.6K
Hsp70-Bag3 Module Regulates Macrophage Motility and Tumor Infiltration via Transcription Factor LITAF and CSF1
Lena Avinery1, Valid Gahramanov1, Arkadi Hesin1
1Department of Molecular Biology, Ariel University, Ariel 407000, Israel.
Cancers
|September 9, 2022
Summary
The Hsp70-Bag3 complex regulates macrophage motility and tumor infiltration by controlling the LITAF-CSF1 pathway. This pathway involves regulating LITAF degradation and subsequent CSF1 chemokine expression.
Area of Science:
- Molecular biology
- Cancer research
- Immunology
Background:
- The molecular chaperone Hsp70 and its co-chaperone Bag3 are involved in cancer development.
- Hsp70 influences cancer cell processes and macrophage tumor infiltration.
- The precise mechanisms by which Hsp70 affects macrophage functions remain unclear.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying Hsp70's regulation of macrophage motility and tumor infiltration.
- To identify key proteins and pathways involved in this process.
Main Methods:
- Co-immunoprecipitation to identify protein interactions.
- Western blotting and quantitative PCR to assess protein and gene expression levels.
- Macrophage motility assays and chemokine level measurements.
Main Results:
- The Hsp70-bound co-chaperone Bag3 interacts with the transcription factor LITAF.
- The Hsp70-Bag3 complex controls LITAF expression by regulating its proteasomal and autophagy-dependent degradation.
- LITAF regulates the expression of the chemokine CSF1, which is crucial for macrophage motility.
- Silencing Bag3 or LITAF reduced macrophage motility, an effect reversed by adding CSF1.
Conclusions:
- A novel Hsp70-Bag3-LITAF-CSF1 pathway controlling macrophage motility and tumor infiltration has been identified.
- This pathway offers potential therapeutic targets for modulating immune cell behavior in cancer.
Related Concept Videos
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Regulation of Angiogenesis and Blood Supply
2.7K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.7K
The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K

